These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 17160428

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Protective efficacy of H2 strain live attenuated hepatitis A vaccines in an outbreak of hepatitis A].
    Zhao Y, Meng Z, Guo J, Wang X, Duo C, Liu H, Yao J, Chai S, Zhu H, Xu Z.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):144-6. PubMed ID: 11860920
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults.
    Vimolket T, Theamboonlers A, Dumas R, Milcamps B, Forrat R, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):779-85. PubMed ID: 10772564
    [Abstract] [Full Text] [Related]

  • 6. Active immunisation during an outbreak of hepatitis A in a German day-care centre.
    Hauri AM, Fischer E, Fitzenberger J, Uphoff H, Koenig C.
    Vaccine; 2006 Jul 17; 24(29-30):5684-9. PubMed ID: 16730103
    [Abstract] [Full Text] [Related]

  • 7. Modeling the long-term persistence of hepatitis A antibody after a two-dose vaccination schedule in Argentinean children.
    López EL, Contrini MM, Mistchenko A, Kieffer A, Baggaley RF, Di Tanna GL, Desai K, Rasuli A, Armoni J.
    Pediatr Infect Dis J; 2015 Apr 17; 34(4):417-25. PubMed ID: 25764099
    [Abstract] [Full Text] [Related]

  • 8. The epidemiology and control of hepatitis A.
    Maguire H, Heptonstall J, Begg NT.
    Commun Dis Rep CDR Rev; 1992 Sep 11; 2(10):R114-7. PubMed ID: 1284926
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine.
    McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L.
    Arch Pediatr Adolesc Med; 1996 Jul 11; 150(7):733-9. PubMed ID: 8673200
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
    Ma F, Yang J, Kang G, Sun Q, Lu P, Zhao Y, Wang Z, Luo J, Wang Z.
    Clin Microbiol Infect; 2016 Sep 11; 22(9):811.e9-811.e15. PubMed ID: 27345175
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1996 Dec 27; 45(RR-15):1-30. PubMed ID: 9005304
    [Abstract] [Full Text] [Related]

  • 18. Prevention and control of hepatitis A.
    Drug Ther Bull; 1994 Feb 17; 32(2):9-11. PubMed ID: 7635017
    [Abstract] [Full Text] [Related]

  • 19. Protection against hepatitis A by an inactivated vaccine.
    Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, Suntayakorn S, Suknuntapong T, Safary A, Tang DB.
    JAMA; 1994 May 04; 271(17):1328-34. PubMed ID: 8158817
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.